Deep Learning

Discovering processed drugs to fight liver fibrosis

Liver fibrosis is a scarring process that can lead to cirrhosis, which causes more than 1.4 million deaths per year. Geneticist Gary Peltz of...

Combining biological toolkits for a modern approach to ALS

Ritu Raman of MIT and Ryan Flynn of Boston Children's Hospital approach human biology with very different sets of tools, but a co-scientist brings...

Accelerating the discovery of liver disease mechanisms

Biomedical research generates a flood of information that no scientist can realistically absorb. At the University of Edinburgh, bioengineer Filippo Menolascina uses Co-Scientist to...

Opening recent paths in aging research

Few problems in medicine are more intricate and more consequential than aging. Overlapping biological processes often determine how long people can live in good...

Finding the molecular switches behind novel infectious diseases

Most emerging infectious diseases are caused by pathogens that jump from animals to humans, such as Ebola, HIV, influenza and Covid-19. Professor Clare Bryant...

Empowering Singapore’s AI Future: A Novel National Partnership

Collaborating to apply pioneering AI to advance health and life sciences, reimagine classrooms and support the workforce of tomorrow.At Google DeepMind, we believe that...

Make it easier to understand how to create and edit content

As generative media becomes more advanced and accessible, it's vital to know where content comes from and whether it has been altered. Today, we're...

We are launching the Google DeepMind Accelerator program in the Asia-Pacific region to address environmental threats.

The Asia-Pacific region is a global driver of economic growth, but it is also highly vulnerable to climate change. Although green technologies are gaining...